ST Pharm's Q3 Operating Profit Rises 6.6% YoY to KRW 15.7 Billion
ST Pharm said in a regulatory filing on Oct. 27 that its consolidated operating profit for the third quarter of this year was provisionally tallied at KRW 15.7 billion, up 6.6% from a year earlier.
Hot Picks Today
"They're Coming After My Pension Too?" Public Unease Mounts... Spain Sees Mass Protest Over Reform Push
- "Where Do You Go Every Lunch Break?"... 'Time-Poor' Men in Their 40s: Where They Spend Their Money.
- "Naked Again?" Controversial Actress Crosses a Line... Slammed for Sexualizing 'Child Characters'
- More Former Employee Allegations About Hey Jini's Workplace... "Cunningly Exploited Without Breaking the Law"
- "A Really Beautiful Butt"... How Did Nicki Minaj React to Trump's Unexpected Remark?
Revenue rose 19.1% year over year to KRW 97.6 billion, while net profit fell 94.8% to KRW 910 million.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
